Communiqués Veloxis Pharmaceuticals A/S

Actions

VELO

DK0060048148

Produits pharmaceutiques

Temps Différé Nasdaq Copenhagen Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^DKK	-.--%		-.--%	-0,50%

30/05/24	Veloxis Pharmaceuticals A/S choisit de présenter ses travaux au 2024 American Transplant Congress à Philadelphie	CI
28/06/22	Veloxis Pharmaceuticals annonce le dosage du premier patient par son partenaire Xenikos dans l'étude mondiale de phase 3 évaluant T-Guard(R) chez les patients atteints de la maladie aiguë du greffon contre l'hôte réfractaire aux stéroïdes (SR-aGVHD)	CI

Communiqués

17/02/20	Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020	AQ
29/01/20	Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S	AQ
27/01/20	Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S	AQ
27/01/20	Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications	AQ
27/01/20	Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting	AQ
24/01/20	Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting	AQ
24/01/20	Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen	AQ
24/01/20	Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S	AQ
24/01/20	Veloxis Pharmaceuticals A/S: Major Shareholder Notifications	AQ
23/01/20	Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer	AQ
20/01/20	Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer	AQ
17/01/20	Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer	AQ
16/01/20	Veloxis Pharmaceuticals A/S : - Reporting of Managers and Closely Associated Persons Transactions in Veloxis-Shares and Financial Instruments Linked Hereto	AQ
16/01/20	Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications	AQ
16/01/20	Veloxis Pharmaceuticals A/S : - Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants	AQ
15/01/20	Veloxis Pharmaceuticals: Reporting of Managers' and Closely Associated Persons' Transactions in Veloxis-Shares and Financial Instruments Linked Hereto	AQ
15/01/20	Veloxis Pharmaceuticals: Major Shareholder Notifications	AQ
15/01/20	Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants in Veloxis Pharmaceuticals	AQ
13/01/20	Veloxis Pharmaceuticals A/S : - Reminder of the deadline for acceptance of Asahi Kasei Pharma Denmark's public takeover offer	AQ
13/01/20	Veloxis Pharmaceuticals A/S : - Reminder of Approaching Deadline for the Acceptance of the Public Tender Offer by Asahi Kasei Pharma Denmark	AQ
12/01/20	Veloxis Pharmaceuticals: Reminder of Approaching Deadline for the Acceptance of the Public Tender Offer by Asahi Kasei Pharma Denmark	AQ
10/01/20	Veloxis Pharmaceuticals A/S : - Competition approvals obtained for the public tender offer by Asahi Kasei Pharma Denmark for the shares and warrants in	AQ
09/01/20	Veloxis Pharmaceuticals: Competition approvals obtained for the public tender offer by Asahi Kasei Pharma Denmark for the shares and warrants in Veloxis Pharmaceuticals	AQ
30/12/19	Veloxis Pharmaceuticals A/S : Announces Financial Calendar for 2020	AQ
18/12/19	Veloxis Pharmaceuticals A/S : - Asahi Kasei Pharma Denmark announces it has now received acceptances from shareholders and warrantholders to meet minimum acceptance condition	AQ